ENDRA Life Sciences (NDRA) Cash & Current Investments: 2016-2021
Historic Cash & Current Investments for ENDRA Life Sciences (NDRA) over the last 6 years, with Sep 2021 value amounting to $11.8 million.
- ENDRA Life Sciences' Cash & Current Investments rose 210.90% to $11.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $49.9 million, marking a year-over-year increase of 261.15%. This contributed to the annual value of $7.2 million for FY2020, which is 17.06% up from last year.
- ENDRA Life Sciences' Cash & Current Investments amounted to $11.8 million in Q3 2021, which was down 16.02% from $14.0 million recorded in Q2 2021.
- Over the past 5 years, ENDRA Life Sciences' Cash & Current Investments peaked at $16.8 million during Q1 2021, and registered a low of $133,679 during Q1 2017.
- Its 3-year average for Cash & Current Investments is $6.6 million, with a median of $3.9 million in 2019.
- Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 9,136.41% in 2017, then slumped by 90.87% in 2018.
- Over the past 5 years, ENDRA Life Sciences' Cash & Current Investments (Quarterly) stood at $5.6 million in 2017, then grew by 15.52% to $6.5 million in 2018, then fell by 4.59% to $6.2 million in 2019, then increased by 17.06% to $7.2 million in 2020, then soared by 210.90% to $11.8 million in 2021.
- Its last three reported values are $11.8 million in Q3 2021, $14.0 million for Q2 2021, and $16.8 million during Q1 2021.